This study will provide evidence on the prevalence and prognostic value of sarcopenia at diagnosis among KPNC colorectal cancer patients diagnosed from 2005-2013. Sarcopenia will be assessed through the qualitative determination of an expert radiologist using visual inspection, and validated against research staff’s semi-quantitative assessment using SliceOmatic software. Radiology, oncology and physical therapy providers will be surveyed about acceptance, relevant workflows, barriers and facilitators to implementing a referral system for physical therapy or resistance training among patients determined to have low muscle at diagnosis.
Novel approaches to identify sarcopenia in newly diagnosed cancer patients
Investigator:
Funder: Northern California Community Benefit Programs
